← All Lifemd, INC filings

Lifemd, INC DEF 14A proxy statements

Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.

NASDAQ
LFMD
Lifemd, INC
DEFA14A: LifeMD, Inc. Files Definitive Proxy Statement
LifeMD, Inc. has filed a definitive proxy statement with the Securities and Exchange Commission.
NASDAQ
LFMD
Lifemd, INC
DEF: LifeMD, Inc. Announces Details for 2025 Annual Stockholders Meeting
LifeMD, Inc. has released its proxy statement detailing the agenda for its upcoming virtual annual meeting of stockholders on June 13, 2025, including the election of directors and ratification of the company's independent accounting firm.
NASDAQ
LFMD
Lifemd, INC
DEFR14A: LifeMD Seeks Stockholder Approval for Amended Equity and Incentive Plan
LifeMD is asking stockholders to approve an amendment to its 2020 Equity and Incentive Plan, increasing the share pool by 3,000,000 and raising the non-employee director compensation limit to $500,000.
NASDAQ
LFMD
Lifemd, INC
DEFA14A: LifeMD, Inc. Files Definitive Proxy Statement
LifeMD, Inc. has filed a definitive proxy statement with the Securities and Exchange Commission.
NASDAQ
LFMD
Lifemd, INC
DEF 14A: LifeMD Seeks Stockholder Approval for Amended Equity Incentive Plan
LifeMD is asking stockholders to approve an amendment to its 2020 Equity and Incentive Plan to increase the number of shares available for issuance by 3,000,000.